EBMT 2016

Mohamad Mohty on EBMT 2016

Defibrotide: Redefining the treatment for severe veno-occlusive disease (sVOD)

Paul Richardson

Blinatumomab for treating ALL

Giovanni Martinelli

Monoclonal antibodies for difficult-to-treat multiple myeloma

Transforming healthcare with Twitter: A physician’s perspective

Navneet Majhail

Graft-versus-host disease (GvHD): Advances at EBMT 2016

New monoclonal antibodies for ALL treatment

Engaging healthcare professionals and patients with social media

Michael Thompson

Change of landscape in CLL treatment

Strategies to reduce graft-versus-host disease (GvHD)

Miguel-Angel Perales

Key questions in the field of CD19 CAR T-cell therapy

Catherine Bollard

Separation of graft-versus-leukemia from graft-versus-host disease (GvHD)

Big topics for nurses at EBMT 2016

The not-invented-here syndrome in nursing research

The changing role of nurses in bone marrow biopsies

Overview of Phase III clinical trial UKALL14 for ALL

1
2
3
4
Next